- About the Patient-Generated Hypotheses Journal
- About the Patient-Led Research Collaborative
- Acknowledgements and contact
- Advocacy
- Balvi Funding Press Release
- Biden Long COVID Announcement
- Clinician’s Pacing and Management Guide for ME/CFS and Long COVID
- Community polls: Informal social media polls: SARS-CoV-2 reinfection and Long COVID, and the presence of new eye floaters in Long COVID and ME/CFS
- Contact Us
- Convocação para Colaboradores do PLRC
- COVID Reinfections FAQ
- COVID-19 Patient Experience Survey
- Donate to PLRC
- EClinicalMedicine Research Paper
- FAQ
- Hypothesis: Astrocyte dysregulation of sympathetic nervous system causes metabolic dysfunction in subset of Long COVID and ME/CFS patients
- Hypothesis: Could vascular damage caused by massive inflammatory events underlie a relapse/recovery phenotype of ME/CFS and Long COVID?
- Hypothesis: Increasing serum soluble CD40 ligand (sCD40L) may be a biomarker of ME/CFS and chronic Long COVID progression
- Hypothesis: Long COVID brain fog is caused by free glycan sugar chains in the brain
- Hypothesis: Matrix metalloproteinase inhibition with low-dose doxycycline in Long COVID and ME/CFS
- Hypothesis: Symptomatic myodesopsia/vitreous floaters may constitute a risk factor for Long COVID and ME/CFS
- Impact
- LISA MCCORKELL NAMED TO NATURE’S 10: TEN PEOPLE WHO HELPED SHAPE SCIENCE IN 2022
- Newsletter-January 2023
- Newsletter-June 2023
- Open Letter regarding the RECOVER initiative to study Long COVID
- Patient-Generated Hypotheses Journal
- Patient-Generated Hypotheses Journal for Long COVID & Associated Conditions — Issue 1, May 2023
- Patient-Generated Hypotheses Journal Issue 1
- PATIENT-LED RESEARCH COLLABORATIVE ANNOUNCES $4.8 MILLION IN BIOMEDICAL RESEARCH AWARDS FOR LONG COVID AND ASSOCIATED CONDITIONS
- Patient-Led Research Collaborative Receives $3M in Funding for Long COVID Research from Balvi, A New Fund for High-Impact COVID Projects from Ethereum Co-Founder Vitalik Buterin
- Patient-Led Research Fund Q&A
- PLRC Call for Collaboration
- PLRC CO-FOUNDER HANNAH DAVIS NAMED TO TIME100 NEXT — TIME’S LIST OF THE NEXT 100 MOST INFLUENTIAL PEOPLE IN THE WORLD
- PLRC 呼籲合作
- Press
- Press Releases
- Publications
- Publications
- Reinfections Study
- Research Team
- Resources for Clinicians
- Resources for Long COVID Researchers
- Resources for Patients
- Select Citations
- Transparency
- Vaccine Survey
